Emergency Medicine

Research

Information/Contact
Contact Information
Close
Division: 
Emergency Medicine
Director: 
F. Meridith Sonnett, MD
Email: 
fs84@columbia.edu
Phone: 
(212) 305-9825
Administrator: 
Michael DeGuzman
Phone: 
(212) 305-3381
Fax: 
(212) 305-6792

The goal of the PECARN network is to conduct meaningful and rigorous multi-institutional research into the prevention and management of acute illnesses and injuries in children and youth across the continuum of emergency medicine health care. PECARN provides the leadership and infrastructure needed to promote multi-center studies, support research collaboration among EMSC investigators, and encourage informational exchanges between EMSC investigators and providers. Researchers within the division have conducted studies that include the following:

  • Pediatric Outcomes In Simulation Education
  • Decision Support to Implement the PECARN Traumatic Brain Injury Prediction Rules
  • RNA Bio-Signatures in Emergency Evaluation of Febrile Infants
  • Fluid Therapy and Cerebral Injury in Pediatric Diabetic Ketoacidosis
  • A multicenter randomized control trail to study the effectiveness of oral dexamethasone for acute bronchiolitis
  • The use of Lorazepam for the treatment of pediatric status epilepticus
  • Childhood Head Trauma: A Neuroimaging Decision Rule
  • Multicenter study to assess the risk of intracranial abnormalities, clinical findings, and management patterns for children with first apparently unprovoked seizures
  • Prospective study of the three view abdominal radiograph series in the diagnosis of intussusception
  • Assessment of caregiver stress and burden due to patient disposition: development of patient- based endpoints
  • Pilot study to determine the feasibility and potential utility of ultrasound for the detection of peripheral veins and insertion of intravenous catheters in children who present to the Emergency Department
  • A randomized clinical trial to determine the efficacy of outpatient nebulized Ipratropium Bromide in the management of children discharged from the PED with asthma
  • A Multicenter, randomized, double-blind study comparing the clinical effects of intravenous Montelukast with placebo in pediatric patients with acute asthma